(1998). Greenberg HB: Identification of mutations in the rotavirus protein VP4 that alter sialic-acid-dependent infection.
(2006). HB: Characterization of a panel of cell lines derived from urothelial neoplasms: genetic alterations, growth in vivo and the relationship of adenoviral mediated gene transfer to coxsackie adenovirus receptor expression.
(2002). Heo DS: Reduced expression of coxsackievirus and adenovirus receptor (CAR) in tumor tissue compared to normal epithelium in head and neck squamous cell carcinoma patients. Anticancer Res
(2001). Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol
(1999). Hsieh JT: Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res
(2009). Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. Blood
(2006). Humphries MJ: Integrin ligands at a glance.
(2001). Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism. Gene Ther
(2000). Integrins alpha2beta1 and alpha4beta1 can mediate SA11 rotavirus attachment and entry into cells.
(1992). Integrins: versatility, modulation, and signaling in cell adhesion. Cell
(2000). JT: The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res
(1995). KM: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science
(2007). Kuritzkes DR: Chemokine antagonists as therapeutics: focus on HIV-1. Annu Rev Med
(2005). LA: Virus Taxonomy;
(2009). Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression.
(1998). Mackow ER: beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure.
(2002). McCormick F: Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res
(1996). Nemerow GR: Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells.
(2007). Nemerow GR: Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol
(2001). Nemerow GR: Integrin alpha(v)beta1 is an adenovirus coreceptor.
(1993). Nemerow GR: Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell
(1999). PL: Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin.
(2003). PR: CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivo. Aids
(1984). RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature
(2001). Raaij MJ: Kinetic analysis of adenovirus fiber binding to its receptor reveals an avidity mechanism for trimeric receptor-ligand interactions.
(2003). Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates. Hum Gene Ther
(2003). Saggio I: Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5. J Virol
(2005). SP: Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. Urology
(1999). Stoppelli MP: Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinasedependent cell migration in breast cancer. Cancer Res
(1996). The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell
(2009). The cell adhesion molecule "CAR" and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution. PLoS Pathog
(1986). The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell
(1968). U: Virus-receptor interaction in an adenovirus system.
(1997). Vitronectin expression in differentiating neuroblastic tumors: integrin alpha v beta 5 mediates vitronectin-dependent adhesion of retinoic-aciddifferentiated neuroblastoma cells.
(1996). Wickham TJ: Comparative analysis of adenovirus fiber-cell interaction: adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment.
(2001). Wickham TJ: Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions.
(2003). WM: Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor. Proc Natl Acad Sci USA
(2003). WM: Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells. Cancer Res
(1998). WSM: Preparation and titration of CsCl-banded adenovirus stock. Methods in Molecular Medicine